Himalaquinones A–G, seven
new anthraquinone-derived metabolites,
were obtained from the Himalayan-based Streptomyces sp. PU-MM59. The chemical structures of the new compounds were identified
based on cumulative analyses of HRESIMS and NMR spectra. Himalaquinones
A–F were determined to be unique anthraquinones that contained
unusual C-4a 3-methylbut-3-enoic acid aromatic substitutions, while
himalaquinone G was identified as a new 5,6-dihydrodiol-bearing angucyclinone.
Comparative bioactivity assessment (antimicrobial, cancer cell line
cytotoxicity, impact on 4E-BP1 phosphorylation, and effect on axolotl
embryo tail regeneration) revealed cytotoxic landomycin and saquayamycin
analogues to inhibit 4E-BP1p and inhibit regeneration. In contrast,
himalaquinone G, while also cytotoxic and a regeneration inhibitor,
did not affect 4E-BP1p status at the doses tested. As such, this work
implicates a unique mechanism for himalaquinone G and possibly other
5,6-dihydrodiol-bearing angucyclinones.